Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Journal of Family Medicine and Primary Care|November 5, 2019
Study of maternal outcome in referral obstetric cases in a tertiary care centreRekha Jakhar, Ankita ChoudharyCureus|May 25, 2023
Psoriasis: A Primer for General PhysiciansShalini Dasari, Ankita Choudhary, Bhushan MadkeCureus|May 14, 2023
Photoaging: Reversal of the Oxidative Stress Through Dietary Changes and Plant-Based ProductsReet Hooda, Bhushan Madke, Ankita ChoudharyIndian Dermatology Online Journal|April 24, 2023
A Rare Case of Congenital Herpes Simplex Virus Infection with Therapeutic Response to AcyclovirNeha C Jangid, Ankita Choudhary, Bela J ShahIndian Journal of Dermatology|February 3, 2025
Psychotropic Drugs in Dermatology Part 1: Anti-depressants and Mood StabilisersVarsha L Kenkare, Bhushan Madke, Ankita Choudhary, et al.Indian Journal of Dermatology|March 31, 2025
Psychotropic Drugs in Dermatology. Part 2: Antipsychotics, Sedative-Hypnotics and Anxiolytics in DermatologyAnkita Choudhary, Shiti Bose, K L Varsha, et al.Indian Dermatology Online Journal|April 24, 2023
The Enigma of Periorificial Desquamating Lesions in a ChildAnkita Choudhary, Rutvi M Pandya, Rima Joshi, et al.Cureus|June 23, 2025
Long-Term Outcomes of Valve Replacement With Mechanical Prosthesis in Patients With Valvular Heart Disease: A Single-Center Retrospective StudyDevendra Saksena, Ankita Choudhary, Sandeep Varma, et al.Clinical, Cosmetic and Investigational Dermatology|February 28, 2022
A Comparative, Three-Arm, Randomized Clinical Trial to Evaluate the Effectiveness and Tolerability of Bilastine vs Fexofenadine vs Levocetirizine at the Standard Dose and Bilastine vs Fexofenadine at Higher Than the Standard Dose (Up-Dosing) vs Levocetirizine and Hydroxyzine (in Combination) in Patients with Chronic Spontaneous UrticariaBela Shah, Dhiraj Dhoot, Ankita Choudhary, et al.The Australasian Journal of Dermatology|July 25, 2023
A single-centre prospective study comparing efficacy and safety of apremilast with cyclosporine in moderate to severe atopic dermatitisHarshita R Vyas, Shikha R Shah, Bela J Shah, et al.Pageof 2